Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Why Smartphones Will Propel AAPL Stock to All-Time Highs

Apple's iOS continues to gain global market share at Google Android's expense, setting up a potential run for AAPL stock.

5 Stocks With Great Earnings Surprises — WRI ABMD CRTO RDCM BRE

This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Superb Earnings Momentum — KNSY CPN PBF FTEK EVAC

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

Will Silver Turn Things Around in 2015?

At this point, I believe SSRI is in a strong enough technical position to rebound to at least $7.47 without encountering much resistance.

10 Insurance Stocks to Buy Now

The grades of 10 insurance stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

13 Semiconductor Stocks to Buy Now

This week, 13 semiconductor stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

11 Biotechnology Stocks to Buy Now

This week, 11 biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

7 Specialty Retail Stocks to Buy Now

The grades of seven specialty retail stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Packaged Foods Stocks to Buy Now

This week, five packaged foods stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

Home Builders May Be Unlikely Winners in 2015

Home builders have been unloved by investors, but housing stocks like TOL, PHM and LEN have actually soared lately ... and look good in 2015.

AA Stock – Join Alcoa for a Strong 2015

Alcoa Inc (AA) is always the first to report earnings, and AA stock did not disappoint when it reported its fourth-quarter and full-year results after the closing bell last night.

Wells Fargo & Co. (WFC): Profits from Prudence

Wells Fargo & Co. is set for stellar growth in 2015. The latest WFC earnings report underscores the rewards of banking boldness that's leavened with common sense.

INTC Stock – From CES to NRF, Intel Is a Hit Everywhere

Intel may have missed the boat on mobility, but it's way ahead of the pack when it comes to building out the wearables and IoT sectors.

Brinker International (EAT) Super-Sizing Profits

Brinker International is a leader in providing slightly fancier, sit-down fast food, setting the table for EAT stock to sizzle. As a major purveyor of "fast casual" fare, Brinker is positioned to ride the global rise in fast food consumption.

5 Gold and Silver Stocks Ready for New Money

Gold and silver stocks continue to consolidate and prepare for major upside moves in the near future.

5 Financial Services Stocks to Buy Now

This week, five financial services stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Health Care Provider Stocks to Buy Now

Five health care provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Superb Cash Flow — YONG ZA PT GURE CGA

This week, these five stocks have the best ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

5 Biotech Stocks With Explosive Drug Pipelines

For many biotech stocks, drug pipelines -- not trailing results -- determine their actual value. That's good news for investors in these 5 biotechs.